Beta

Proposal:Conditional Approval Act

This proposal is archived and closed to further debate. It was introduced in the 116th Congress, which has concluded, and the bill was not enacted into law.
Geographic Scope
National

Description

Conditional Approval Act

This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.

Bill Title

Conditional Approval Act

Linked Goals

Steps

  • 2019-12-19: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • 2019-12-19: Introduced in Senate

Projected Outcome

A more informed proposal or public response aligned with the Promote General Welfare goal.